Nxera Pharma UK Limited is a specialized research and development company focused on biotechnology solutions, operating primarily within the pharmaceutical and healthcare sectors. Established in 2007, the company maintains a registered status with the UK’s regulatory authorities and is currently active. Nxera specializes in the development of novel therapies and diagnostic tools utilizing advanced molecular biology and protein engineering techniques. The company’s core services encompass preclinical research, drug discovery, and formulation development, with a particular emphasis on targeted therapies for unmet medical needs. Nxera’s key focus lies in identifying and validating novel targets for therapeutic intervention. They offer contract research and development services to pharmaceutical companies and research institutions globally. Nxera’s international presence is currently established, with a dedicated team operating within Europe and North America. The company employs a skilled workforce, including experienced scientists and technicians, and maintains a relatively small workforce size. As a limited company, Nxera Pharma UK Limited is classified under SIC codes related to biotechnology research and development. The company’s SIC industry focus includes pharmaceutical development, molecular biology, and protein engineering. Contact information is available on their website.

Nxera Pharma UK Limited is a specialized research and development company focused on biotechnology solutions, operating primarily within the pharmaceutical and healthcare sectors. Established in 2007, the company maintains a registered status with the UK’s regulatory authorities and is currently active. Nxera specializes in the development of novel therapies and diagnostic tools utilizing advanced molecular biology and protein engineering techniques. The company’s core services encompass preclinical research, drug discovery, and formulation development, with a particular emphasis on targeted therapies for unmet medical needs. Nxera’s key focus lies in identifying and validating novel targets for therapeutic intervention. They offer contract research and development services to pharmaceutical companies and research institutions globally. Nxera’s international presence is currently established, with a dedicated team operating within Europe and North America. The company employs a skilled workforce, including experienced scientists and technicians, and maintains a relatively small workforce size. As a limited company, Nxera Pharma UK Limited is classified under SIC codes related to biotechnology research and development. The company’s SIC industry focus includes pharmaceutical development, molecular biology, and protein engineering. Contact information is available on their website.